Bismuth Potassium Citrate

also known as Bismuth · Bismuth citrate · bismuth tripotassium dicitrate · Bismuth sodium tartrate · Li Zhu De Le · Lizhu Delle · Natrol

Developed for: Helicobacter pylori infectious disease · dyspepsia · peptic ulcer disease · aphthous stomatitis · gastric cancer · microscopic colitis · pancreatic ductal adenocarcinoma · sleep disorder
+3 more
· chronic gastritis · gastritis · stomach disorder
Investigated by: Shanghai Jiao Tong University School of Medicine · Shandong University · Heze Municipal 3rd people's hospital · Maternity and Child Care Health Center of Dezhou · Peking University Care Luzhong Hospital · Shanghai Zhongshan Hospital
+43 more
· The People's Hospital of Jimo.Qingdao · Ajou University School of Medicine · AstraZeneca · Azidus Brasil · Chong Kun Dang Pharmaceutical · Dezhou Hospital Qilu Hospital of Shandong University · Feicheng Municipal People's Hospital · Fudan University · Green Cross Corporation · HK inno.N Corporation · Jiangsu Sinorda Biomedicine Co., Ltd · Jining No.2 People's Hospital · Kaohsiung Medical University Chung-Ho Memorial Hospital · Kaohsiung Veterans General Hospital. · Linyi People's Hospital · National Taiwan University Hospital · Norwegian University of Science and Technology · Qihe County City Hospital · Qilu Hospital of Shandong University · SK Chemicals Co., Ltd. · Seoul National University Bundang Hospital · Seoul National University Hospital · Shandong Electric Power Central Hospital · Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. · Shandong Province Third hospital · Shandong University of Traditional Chinese Medicine · Shanghai East Hospital · Sihuan Pharmaceutical Holdings Group Ltd. · Taian City Central Hospital · Takeda · The Affiliated Hospital of Qingdao University · The First Affiliated Hospital with Nanjing Medical University · The People's Hospital of Guangrao · The Third Xiangya Hospital of Central South University · University of Nebraska · Weifang Medical University · Weifang People's Hospital · Weihai Municipal Hospital · Yonsei University · Yuncheng Chengxin Hospital · Zaozhuang Municipal Hospital · Zibo Maternal and Child Health Hospital · Zoucheng People's Hospital

Trials 33

today NCT07576959 · Ph 3 NCT06943794 · not/applicable NCT07232095 · Ph 4 NCT07294846 · Ph 1 NCT06723197 · Ph 4 NCT06561698 · Ph 4 NCT05915871 · Ph 1 NCT05726734 · Ph 4 NCT05586113 · Ph 4 NCT05061732 · Ph 4 NCT05049902 · Ph 4 NCT05014685 · Ph 4 NCT04901117 · Ph 4 NCT04753437 · Ph 1 NCT05410223 · not/applicable NCT04444011 · Ph 1 NCT04006340 · not/applicable NCT03708848 · Ph 4 NCT03730766 · Ph 4 NCT03557437 · Ph 4 NCT03405584 · Ph 4 NCT03413020 · Ph 4 NCT02935010 · Ph 4 NCT02732249 · Ph 4 NCT02570529 · Ph 4 NCT02978157 · not/applicable NCT02159976 · not/applicable NCT01938534 · Ph 4 NCT01667575 · Ph 4 NCT01667718 · Ph 4 NCT00857688 · Ph 3 NCT01033565 · Ph 4 NCT00184171 · not/applicable

2001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028202920302031

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 14 trials
Phase 1	NCT07294846	Sep → Dec 2025	—	Jiangsu Sinorda Biomedicine Co., Ltd	Completed	No outcome recorded
Phase 1	NCT05915871	Mar → Apr 2023	—	Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.	Completed	No outcome recorded
Phase 1	NCT04753437	Apr → Sep 2021	Helicobacter pylori infectious disease	Takeda	Completed	No outcome recorded
Phase 1	NCT04444011	Jul → Sep 2020	—	Sihuan Pharmaceutical Holdings Group Ltd.	Unknown	No outcome recorded
Phase 32 trials
Phase 3	NCT07576959	Apr 2026 → Dec 2030 expected	Helicobacter pylori infectious disease	National Taiwan University Hospital	Recruiting	No outcome recorded
Phase 3	NCT00857688	May → Jun 2011	aphthous stomatitis	Azidus Brasil	Completed	No outcome recorded
Phase 421 trials · 2 met primary
Phase 4	NCT07232095	Jan 2026 → Jun 2027 expected	Helicobacter pylori infectious disease	The First Affiliated Hospital with Nanjing Medical University	Recruiting	No outcome recorded
Phase 4	NCT06723197	Dec 2024 → Oct 2025 overdue	Helicobacter pylori infectious disease	Shandong University	Recruiting	No outcome recorded
Phase 4	NCT06561698	Aug 2024 → Aug 2026 overdue	Helicobacter pylori infectious disease	Shanghai Jiao Tong University School of Medicine	Recruiting	No outcome recorded
Phase 4	NCT05726734	Feb 2023 → Feb 2025	Helicobacter pylori infectious disease	Shanghai East Hospital	Unknown	No outcome recorded
Phase 4	NCT05586113	Feb → Oct 2023	Helicobacter pylori infectious disease	Shandong University	Unknown	No outcome recorded
Phase 4	NCT05061732	Sep 2021 → Jun 2026	Helicobacter pylori infectious disease	Shanghai Zhongshan Hospital	Unknown	No outcome recorded
Phase 4	NCT05049902	Sep 2021 → May 2023	Helicobacter pylori infectious disease	Shandong University	Completed	Met primary
Phase 4	NCT05014685	Aug 2021 → Dec 2022	Helicobacter pylori infectious disease	Shanghai Zhongshan Hospital	Unknown	No outcome recorded
Phase 4	NCT04901117	Jun 2021 → Jun 2023	Helicobacter pylori infectious disease	Shandong University	Unknown	No outcome recorded
Phase 4	NCT03708848	Dec 2018 → Sep 2019	Helicobacter pylori infectious disease	Shanghai Jiao Tong University School of Medicine	Completed	No outcome recorded
Phase 4	NCT03730766	Aug → Nov 2018	Helicobacter pylori infectious disease	Shanghai Jiao Tong University School of Medicine	Unknown	No outcome recorded
Phase 4	NCT03557437	May 2018 → Jun 2019	Helicobacter pylori infectious disease	Shanghai Jiao Tong University School of Medicine	Completed	Met primary
Phase 4	NCT03405584	Jan → Nov 2018	Helicobacter pylori infectious disease	Shanghai Jiao Tong University School of Medicine	Completed	No outcome recorded
Phase 4	NCT03413020	Jan → Jul 2018	Helicobacter pylori infectious disease	Shanghai Jiao Tong University School of Medicine	Completed	No outcome recorded
Phase 4	NCT02935010	Feb 2017 → Mar 2018	Helicobacter pylori infectious disease	Shanghai Jiao Tong University School of Medicine	Completed	No outcome recorded
Phase 4	NCT02732249	Apr 2016 → Sep 2017	Helicobacter pylori infectious disease	Shanghai Jiao Tong University School of Medicine	Completed	No outcome recorded
Phase 4	NCT02570529	Oct 2015 → Oct 2017	pancreatic ductal adenocarcinoma	Yonsei University	Withdrawn	No outcome recorded
Phase 4	NCT01938534	Sep 2013 → Dec 2014	—	Ajou University School of Medicine	Unknown	No outcome recorded
Phase 4	NCT01667575	Aug 2012 → May 2013	Helicobacter pylori infectious disease, dyspepsia, peptic ulcer disease	Shanghai Jiao Tong University School of Medicine	Completed	No outcome recorded
Phase 4	NCT01667718	May → Oct 2012	dyspepsia, peptic ulcer disease	Shanghai Jiao Tong University School of Medicine	Completed	No outcome recorded
Phase 4	NCT01033565	Mar → Oct 2010	sleep disorder	University of Nebraska	Terminated	No outcome recorded Stop: Enrollment

Phase not applicable6 trials · 2 missed
—	NCT06943794	Mar 2026 → May 2030 expected	gastric cancer	Fudan University	Not yet recruiting	No outcome recorded
—	NCT05410223	Apr 2021 → Dec 2022	Helicobacter pylori infectious disease	The Third Xiangya Hospital of Central South University	Unknown	No outcome recorded
—	NCT04006340	Jan → Aug 2019	Helicobacter pylori infectious disease	Seoul National University Hospital	Unknown	Missed primary
—	NCT02978157	Feb 2015 → Sep 2017	Helicobacter pylori infectious disease	Kaohsiung Veterans General Hospital.	Completed	No outcome recorded
—	NCT02159976	Jul 2014 → May 2015	Helicobacter pylori infectious disease	Seoul National University Bundang Hospital	Completed	Missed primary
—	NCT00184171	Nov 2001 → Sep 2010	microscopic colitis	Norwegian University of Science and Technology	Terminated	No outcome recorded
Comparator or background therapy67 trials
Phase 1	NCT04066257 Comparator	Jan → Feb 2019	—	HK inno.N Corporation	Completed	No outcome recorded
Phase 2	NCT01805934 Comparator	May → Dec 2012	—	Shanghai Jiao Tong University School of Medicine	Completed	No outcome recorded
Phase 3	NCT07104318 Comparator	Jan 2027 → Mar 2029 expected	Helicobacter pylori infectious disease	VA Office of Research and Development	Not yet recruiting	No outcome recorded
Phase 3	NCT07606833 Background	Jun 2026 → Feb 2027 expected	Helicobacter pylori infectious disease	Xuanzhu Biopharmaceutical Co., Ltd.	Not yet recruiting	No outcome recorded
Phase 3	NCT06760065 Comparator	Jan 2025 → Dec 2027 expected	Helicobacter pylori infectious disease	Sixth Affiliated Hospital, Sun Yat-sen University	Not yet recruiting	No outcome recorded
Phase 3	NCT07487142 Comparator	Jun 2024 → Dec 2025	Helicobacter pylori infectious disease	Beni-Suef University	Completed	No outcome recorded
Phase 3	NCT05857163 Comparator	May → Dec 2023	Helicobacter pylori infectious disease	TenNor Therapeutics Inc.	Completed	Met primary
Phase 3	NCT04198363 Background	Apr 2020 → Nov 2021	Helicobacter pylori infectious disease	Takeda	Completed	Met primary
Phase 3	NCT03050307 Background	Apr 2017 → Feb 2020	gastric ulcer	Takeda	Completed	No outcome recorded
Phase 3	NCT03050359 Background	Apr 2017 → Mar 2019	duodenal ulcer	Takeda	Completed	No outcome recorded
Phase 3	NCT02557932 Comparator	Sep 2015 → Dec 2018	Helicobacter pylori infectious disease, hereditary gastric cancer	National Cancer Center, Korea	Completed	Met primary
Phase 3	NCT02112214 Comparator	Jun 2014 → Dec 2029 expected	Helicobacter pylori infectious disease, gastric cancer	National Cancer Center, Korea	Active not recruiting	No outcome recorded
Phase 4	NCT07405697 Comparator	Feb 2026 → Dec 2027 expected	Helicobacter pylori infectious disease	Shanghai Zhongshan Hospital	Not yet recruiting	No outcome recorded
Phase 4	NCT07405684 Comparator	Feb 2026 → Dec 2027 expected	Helicobacter pylori infectious disease	Shanghai Zhongshan Hospital	Not yet recruiting	No outcome recorded
Phase 4	NCT07139366 Background	Oct 2025 → Sep 2026 overdue	Helicobacter pylori infectious disease, dyspepsia, gastric cancer, gastritis +1	Yongquan Shi	Recruiting	No outcome recorded
Phase 4	NCT07068607 Comparator	Apr → Oct 2025 overdue	Helicobacter pylori infectious disease, dyspepsia, gastric cancer, gastritis +1	Yongquan Shi	Recruiting	Missed primary
Phase 4	NCT06523764 Comparator	Nov 2024 → Aug 2025 overdue	chronic gastritis	Xijing Hospital of Digestive Diseases	Active not recruiting	No outcome recorded
Phase 4	NCT06514274 Comparator	Sep 2024 → Apr 2025	Helicobacter pylori infectious disease, chronic gastritis	Xijing Hospital of Digestive Diseases	Completed	No outcome recorded
Phase 4	NCT06561711 Background	Aug 2024 → Feb 2026	Helicobacter pylori infectious disease	Shanghai Jiao Tong University School of Medicine	Completed	No outcome recorded
Phase 4	NCT06351891 Background	Apr → Dec 2024	Helicobacter pylori infectious disease	Qilu Hospital of Shandong University	Unknown	Met primary
Phase 4	NCT06603688 Background	Nov 2023 → Nov 2024	Helicobacter pylori infectious disease, chronic gastritis	Xijing Hospital of Digestive Diseases	Unknown	No outcome recorded
Phase 4	NCT06168214 Comparator	Sep 2023 → Nov 2024 overdue	—	Xijing Hospital of Digestive Diseases	Recruiting	No outcome recorded
Phase 4	NCT05874570 Background	Jun 2023 → Oct 2025 overdue	Helicobacter pylori infectious disease	Shanghai Jiao Tong University School of Medicine	Recruiting	No outcome recorded
Phase 4	NCT06168084 Comparator	Jun 2023 → May 2024	stomach disorder	Yongquan Shi	Completed	Met primary
Phase 4	NCT05874544 Comparator	May 2023 → Jan 2025	Helicobacter pylori infectious disease	Shanghai Jiao Tong University School of Medicine	Completed	Mixed
Phase 4	NCT05802888 Background	Mar 2023 → Jun 2024	Helicobacter pylori infectious disease	Shandong University	Unknown	No outcome recorded
Phase 4	NCT05742568 Comparator	Dec 2022 → Dec 2023	Helicobacter pylori infectious disease, dyspepsia, gastric cancer, gastritis +1	Xijing Hospital of Digestive Diseases	Completed	No outcome recorded
Phase 4	NCT05431075 Background	Jul 2022 → Feb 2024	Helicobacter pylori infectious disease	Shandong University	Completed	Met primary
Phase 4	NCT05432115 Background	Jun 2022 → Aug 2023	Helicobacter pylori infectious disease	Shandong University	Unknown	No outcome recorded
Phase 4	NCT05332444 Comparator	Apr 2022 → Dec 2026 expected	Helicobacter pylori infectious disease	National Taiwan University Hospital	Recruiting	No outcome recorded
Phase 4	NCT05196945 Comparator	Mar → Dec 2022	—	Sixth Affiliated Hospital, Sun Yat-sen University	Unknown	No outcome recorded
Phase 4	NCT05250050 Background	Mar → Dec 2022	Helicobacter pylori infectious disease	Shanghai Zhongshan Hospital	Unknown	No outcome recorded
Phase 4	NCT05014334 Comparator	Dec 2021 → Mar 2022	Helicobacter pylori infectious disease, chronic gastritis	Xijing Hospital of Digestive Diseases	Completed	No outcome recorded
Phase 4	NCT05023577 Background	Aug 2021 → Dec 2022	Helicobacter pylori infectious disease	Shanghai Zhongshan Hospital	Unknown	No outcome recorded
Phase 4	NCT05018923 Background	Aug 2021 → Dec 2022	Helicobacter pylori infectious disease	Shanghai Zhongshan Hospital	Unknown	No outcome recorded
Phase 4	NCT04697186 Comparator	Jan → Dec 2021	Helicobacter pylori infectious disease, chronic gastritis, dyspepsia, gastric cancer	Xijing Hospital of Digestive Diseases	Completed	No outcome recorded
Phase 4	NCT04678492 Comparator	Dec 2020 → Dec 2021	Helicobacter pylori infectious disease, dyspepsia, gastric cancer, gastritis +1	Xijing Hospital of Digestive Diseases	Completed	Met primary
Phase 4	NCT04667299 Background	Dec 2020 → Nov 2021	Helicobacter pylori infectious disease	Shanghai Zhongshan Hospital	Unknown	No outcome recorded
Phase 4	NCT04531059 Background	Oct 2020 → Dec 2022	Helicobacter pylori infectious disease	Shanghai Jiao Tong University School of Medicine	Completed	No outcome recorded
Phase 4	NCT04209933 Comparator	May → Aug 2020	Helicobacter pylori infectious disease, gastric cancer	Xijing Hospital of Digestive Diseases	Completed	No outcome recorded
Phase 4	NCT04034641 Background	Jun 2019 → Dec 2020	active peptic ulcer disease	Hangzhou Grand Biologic Pharmaceutical, Inc.	Unknown	No outcome recorded
Phase 4	NCT03609892 Comparator	Aug 2018 → Aug 2019	Helicobacter pylori infectious disease, chronic gastritis, gastric cancer, gastric ulcer	Xijing Hospital of Digestive Diseases	Completed	Met primary
Phase 4	NCT03342456 Background	Dec 2017 → Jun 2019	duodenal ulcer	The Third Xiangya Hospital of Central South University	Completed	No outcome recorded
Phase 4	NCT02633930 Background	Dec 2015 → Jun 2016	dyspepsia, gastritis, peptic ulcer disease	Xijing Hospital of Digestive Diseases	Completed	No outcome recorded
Phase 4	NCT02296021 Comparator	Nov 2014 → Sep 2015	dyspepsia, gastritis, peptic ulcer disease	Xijing Hospital of Digestive Diseases	Completed	No outcome recorded
Phase 4	NCT02175901 Background	Jul 2014 → Jan 2015	dyspepsia, peptic ulcer disease	Shanghai Jiao Tong University School of Medicine	Completed	No outcome recorded
Phase 4	NCT02175927 Background	Jul 2014 → Oct 2015	—	Shanghai Jiao Tong University School of Medicine	Completed	No outcome recorded
Phase 4	NCT02835560 Comparator	Jun 2013 → Jul 2015	—	Livzon Pharmaceutical Group Inc.	Completed	No outcome recorded
Phase 4	NCT01668927 Background	Jul → Sep 2012	dyspepsia, peptic ulcer disease	Shanghai Jiao Tong University School of Medicine	Completed	No outcome recorded
Phase 4	NCT00841854 Comparator	Jun 2008 → May 2010	Helicobacter pylori infectious disease	Asan Medical Center	Completed	No outcome recorded
—	NCT07165444 Comparator	Sep 2025 → Feb 2026 overdue	Helicobacter pylori infectious disease, proton-pump inhibitor-responsive esophageal eosinophilia	Tanta University	Recruiting	No outcome recorded
—	NCT07179159 Comparator	Sep 2025 → Aug 2026 overdue	Helicobacter pylori infectious disease	Yanqing Li	Recruiting	No outcome recorded
—	NCT07130253 Background	Aug 2025 → Jun 2028 expected	Helicobacter pylori infectious disease	National Taiwan University Hospital	Not yet recruiting	No outcome recorded
—	NCT06977841 Comparator	Jun 2025 → Mar 2026	—	Zhongshan Hospital (Xiamen), Fudan University	Completed	No outcome recorded
—	NCT06299605 Comparator	Nov 2024 → Oct 2025	Helicobacter pylori infectious disease	Shandong University	Unknown	No outcome recorded
—	NCT06412588 Comparator	Jun 2024 → Jan 2026	Helicobacter pylori infectious disease	Nanjing First Hospital, Nanjing Medical University	Completed	No outcome recorded
—	NCT05364619 Comparator	Aug 2022 → Dec 2024	Helicobacter pylori infectious disease	Peking University First Hospital	Unknown	No outcome recorded
—	NCT05320133 Comparator	Jun 2022 → Nov 2024	Helicobacter pylori infectious disease	Peking University First Hospital	Unknown	No outcome recorded
—	NCT05189444 Background	Mar → Dec 2022	Helicobacter pylori infectious disease	Huazhong University of Science and Technology	Unknown	No outcome recorded
—	NCT04879992 Comparator	May 2021 → Oct 2022	Helicobacter pylori infectious disease	Shanghai Jiao Tong University School of Medicine	Completed	No outcome recorded
—	NCT04674774 Background	Mar 2021 → Feb 2022	Helicobacter pylori infectious disease	Incheon St.Mary's Hospital	Unknown	No outcome recorded
—	NCT05176821 Comparator	Jan 2021 → Dec 2022	Helicobacter pylori infectious disease	Shanghai Zhongshan Hospital	Unknown	No outcome recorded
—	NCT03688828 Background	Nov 2018 → Jun 2020	Helicobacter pylori infectious disease	Huazhong University of Science and Technology	Completed	No outcome recorded
—	NCT03431688 Comparator	Oct 2018 → Oct 2020	Helicobacter pylori infectious disease	Kangdong Sacred Heart Hospital	Completed	No outcome recorded
—	NCT02894892 Comparator	Nov 2016 → Oct 2017	Helicobacter pylori infectious disease	National Taiwan University Hospital	Completed	No outcome recorded
—	NCT02759029 Comparator	Mar 2016 → Feb 2018	Helicobacter pylori infectious disease	Gangnam Severance Hospital	Unknown	No outcome recorded
—	NCT00892502 Comparator	May 2009 → Jan 2012	leukemia, plasma cell myeloma	Copenhagen University Hospital at Herlev	Completed	No outcome recorded

Evidence & citations 9 cited values

Every value below carries the sentence it was read from. 100 sources stand behind the page.

Field	Value	Cited text
Known as	Bismuth potassium citrate	“Based on the susceptibility results and penicillin-allergic test, a tailored 7-day triple or quadruple therapy regimen is prescribed, including Tegoprazan , Amoxicillin,...” NCT07405697 ↗ 51 “including a proton pump inhibitor (Esomeprazole 20 mg), Bismuth Potassium Citrate 220 mg, and two antibiotics selected based on susceptibility testing (e.g., Amoxicillin,...” NCT06760065 ↗ “In the Tegoprazan-Amoxicillin-Tetracycline-Bismuth Quadruple Therapy group, bismuth potassium citrate capsules 240 mg (Hunan Warner Pharmaceutical Co., Ltd.) were administered...” NCT06977841 ↗ “Ilaprazole -based quadruple therapy for 14 days: Ilaprazole 5mg bid, Bismuth Potassium Citrate 220mg bid, amoxicillin 1000mg bid, clarithromycin 500mg bid” NCT02835560 ↗ “Subjects will receive the rabeprazole 10mg, moxycillin 1.0g, clarithromycin 500mg and bismuth potassium citrate 220mg twice daily for 14 days.” NCT05320133 ↗ “Rabeprazole 20mg twice daily, bismuth potassium citrate 220mg twice daily, Amoxycillin 1g twice daily, clarithromycin 500mg twice daily.” NCT05364619 ↗ “including Tegoprazan , Amoxicillin, Clarithromycin, Levofloxacin, Bismuth Potassium Citrate, Metronidazole, Doxycycline or Minocycline.” NCT07405684 ↗ “Patients were assigned randomly to groups given lansoprazole (30 mg twice daily) and bismuth potassium citrate (220 mg twice daily)” PMID 23376004 ↗ Jan 2013 “1 g Amoxicillin, 500 mg clarithromycin and 600 mg bismuth potassium citrate/bismuth tripotassium dicitrate, twice daily (BID).” NCT03050307 ↗ “1 g Amoxicillin, 500 mg clarithromycin and 600 mg bismuth potassium citrate/bismuth tripotassium dicitrate, twice daily (BID).” NCT03050359 ↗ “Bismuth potassium Citrate (Lizhu Delle, Lizhu Group Pharmaceutical Factory) 2g bid” NCT05586113 ↗ Show 41 more sources
Known as	Bismuth	“oral administration of tegoprazan-based bismuth quadruple therapy(tegoprazan 50 mg b.i.d, bismuth 300 mg q.i.d, metronidazole 500 mg t.i.d, tetracycline 500 mg q.i.d) for 14 days” NCT04674774 ↗ 43 “Bismuth-containing quadruple therapy:Amoxicillin 1000 mg, clarithromycin 500 mg, vonoprazan 20 mg, and colloidal bismuth tartrate 220 mg, all twice a day for 14 days” NCT07068607 ↗ “Lansoprazole 30mg, 2 times a day + Bismuth 300mg, 4 times a day + Tetracycline 500mg, 4 times a day + Metronidazole 500mg, 3 times a day for 10 days” NCT02557932 ↗ “bismuth quadruple therapy: include rabeprazole 20 mg bid, bismuth 120 mg qid, metronidazole 500 mg tid, and tetracycline 500 mg qid, for 14 days” NCT05332444 ↗ “esomeprazole 40 mg and bismuth 300mg twice daily, tetracycline 500 mg four times daily, metronidazole 500mg three times daily for 10 days” NCT04006340 ↗ “Patients will a 10-day course of bismuth, metronidazole, tetracycline four times daily, and vonoprazan 20 mg twice daily.” NCT07165444 ↗ “Tetracycline 500mg four times Omeprazole 30mg twice Bismuth 600mg twice Metronidazole 500mg three times for 10 days” NCT01938534 ↗ “Levofloxacin sequential therapy or bismuth quadruple therapy (10 or 14 days) or quadruple therapy” NCT07130253 ↗ “Vonoprazan 20mg twice daily+Amoxicillin 1g three times daily+Bismuth 220mg twice daily for 7 days” NCT07232095 ↗ “Tid group: Amoxicillin 1000mg bid+ Tetracycline 500mg tid+ Bismuth + Esomeprazole 40mg bid” NCT05432115 ↗ “Tid group: Amoxicillin 1000mg bid+ Tetracycline 500mg tid+ Bismuth + Esomeprazole 40mg bid” NCT05802888 ↗ Show 33 more sources
Known as	Bismuth citrate	“including rabeprazole(10mg bid),bismuth citrate(220mg bid),levofloxacin(200mg qm) and furazolidone(100mg bid).” NCT01805934 ↗ 1 “2. Bismuth citrate: 220mg, 2 times/day” NCT06943794 ↗
Known as	Bismuth sodium tartrate	“Bismuth sodium tartrate, neomycin sulfate, procain hydrocloride” NCT00857688 ↗
Known as	bismuth tripotassium dicitrate	“1 g Amoxicillin, 500 mg clarithromycin and 600 mg bismuth potassium citrate/bismuth tripotassium dicitrate, twice daily (BID).” NCT03050359 ↗ 1 “1 g Amoxicillin, 500 mg clarithromycin and 600 mg bismuth potassium citrate/bismuth tripotassium dicitrate, twice daily (BID).” NCT03050307 ↗
Known as	Li Zhu De Le	“bismuth potassium citrate granules (Li Zhu De Le)” NCT04034641 ↗
Known as	Lizhu Delle	“Bismuth potassium Citrate (Lizhu Delle, Lizhu Group Pharmaceutical Factory) 2g bid” NCT05586113 ↗
Known as	Natrol	ClinicalTrials.gov intervention name — accepted as the source's own label NCT01033565 ↗
Route	Oral	“Bismuth 220 mg, esomeprazole 20 mg, amoxicillin 1000 mg, and clarithromycin 500 mg by mouth,twice daily for 14 days.” NCT02296021 ↗